Pal-AHK's Role in Follicular Cell Growth and Apoptosis Reduction

Pal-AHK, a palmitoylated tripeptide of alanine-histidine-lysine, shows potential in modulating dermal papilla cells central to hair follicle regulation. Studies indicate it reduces apoptosis in these cells by 3.48% and lowers active caspase-3 by 42.7%, alongside boosting collagen production by 300%…

# Pal-AHK's Role in Follicular Cell Growth and Apoptosis Reduction

Pal-AHK consists of the tripeptide alanine-histidine-lysine with a C16 fatty acid chain attached to the N-terminus through palmitoylation. 1 This modification enhances the compound's lipophilicity, while the core sequence binds strongly to copper ions. Such properties position Pal-AHK for research into dermal papilla cells DPCs , key regulators of hair follicles via influences on proliferation, cell death, and blood vessel formation.

Chemical Structure of Pal-AHK

Analysis by Kecel-Gunduza et al. indicates the AHK sequence binds copper ions effectively, mainly through the histidine residue's imidazole side chain coordinating Cu²⁺. 2 Lysine's amino group adds stability to this interaction, and alanine offers flexibility. Palmitoylation links the C16 chain to alanine's N-terminus without affecting histidine's binding site, aiding passage through lipid-rich cell models.

For detailed peptide structures, consult the Peptide Glossary /tools/peptide-glossary .

Anti-Apoptotic Effects on Dermal Papilla Cells

Research by Sadgrove et al. points to Pal-AHK lowering TGF-β1 expression, extending hair shaft length, raising vascular endothelial growth factor levels, and curbing negative growth factors. 3 Pyo et al. found exposure to the peptide boosts proliferation and differentiation in follicular epithelial cells. 4

Copper-bound Pal-AHK cuts apoptosis in DPCs by about 3.48%, confirmed at the protein level through Bcl-2 family shifts favoring anti-apoptotic members. Since Bcl-2 rises during the telogen-to-anagen shift, this change aligns with hair cycle reactivation. Caspase-3 activity drops by 42.7%, and its target PARP decreases by 77.5%, with procaspase-3 levels steady.

Growth Factor Modulation and Vascular Support

Due to similarities with GHK, Pal-AHK may elevate VEGF for better perifollicular blood supply and follicle growth, while suppressing DPC-derived TGF-β1 that hinders epithelial proliferation. These shifts support cell survival and growth in follicle models.

Stimulation of Collagen in Fibroblasts

Patt et al. report copper-bound Pal-AHK enhances dermal fibroblast growth and survival, promoting collagen output. 5 Fibroblasts produce most collagen and matrix proteins, so these effects enable matrix changes.

In cultures, the peptide raises collagen type I secretion by roughly 300% over controls, acting beyond mere growth stimulation to activate biosynthesis. Copper binding also aids lysyl oxidase in crosslinking collagen and elastin, activates matrix metalloproteases, and fosters new vessels via VEGF.

Lab researchers handling peptides like Pal-AHK can benefit from tools such as the Purity Analyzer /tools/peptide-purity-calculator and Reconstitution Calculator /tools/peptide-reconstitution-calculator .

Key Research Implications

Studies highlight Pal-AHK's interactions with copper and cells in hair follicles and skin matrix. Reductions in apoptosis markers and boosts in collagen point to focused cellular effects. Ongoing work with DPCs and fibroblasts underscores its research value in growth regulation.

Peptides referenced: Pal-AHK.

Related reading: Complete Guide to Peptides in Canada: 2026 Edition, Endotoxin-Free Peptides: Key to Accurate T Cell Assays, Peptide Binding Affinity Analysis: Methods and Best Practices, Peptide Drug Discovery: From Concept to Candidate.